Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.00
-0.52 (-1.89%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Assembly Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -6.12 | -40.18 | -61.23 | -93.09 | -129.86 | |
| Depreciation & Amortization | 0.13 | 0.13 | 0.45 | 0.5 | 0.47 | |
| Loss (Gain) From Sale of Assets | - | - | 0.14 | - | -1.38 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 41.64 | |
| Loss (Gain) From Sale of Investments | -2.35 | -3.66 | -1.59 | 0.16 | 0.59 | |
| Stock-Based Compensation | 4.68 | 3.12 | 5.12 | 6.59 | 5.24 | |
| Other Operating Activities | 0.85 | 1.42 | 3.51 | 3.51 | 1.31 | |
| Change in Accounts Receivable | -0.97 | 0.04 | 0.9 | -0.61 | 0.89 | |
| Change in Accounts Payable | 0.59 | 0.12 | -2.03 | -0.17 | -1.94 | |
| Change in Unearned Revenue | -36.1 | -13.29 | 83.56 | - | -6.25 | |
| Change in Other Net Operating Assets | -1.8 | 1.18 | -6.09 | -1.35 | -4.1 | |
| Operating Cash Flow | -41.09 | -51.12 | 22.74 | -84.46 | -93.4 | |
| Capital Expenditures | -0.07 | -0.03 | -0.26 | -0.1 | -3.1 | |
| Sale of Property, Plant & Equipment | - | - | 0.02 | 1.5 | 2.36 | |
| Investment in Securities | -113.4 | 40.2 | -68.91 | 89.24 | 27.25 | |
| Investing Cash Flow | -113.47 | 40.17 | -69.14 | 90.64 | 26.52 | |
| Issuance of Common Stock | 174.67 | 29.45 | 13.82 | 0.61 | 53.06 | |
| Financing Cash Flow | 174.67 | 29.45 | 13.82 | 0.61 | 53.06 | |
| Net Cash Flow | 20.11 | 18.5 | -32.58 | 6.79 | -13.82 | |
| Free Cash Flow | -41.16 | -51.15 | 22.49 | -84.57 | -96.49 | |
| Free Cash Flow Margin | -56.93% | -179.33% | 313.95% | - | -1542.88% | |
| Free Cash Flow Per Share | -3.67 | -8.52 | 4.91 | -20.96 | -26.75 | |
| Cash Income Tax Paid | - | 0.4 | - | - | - | |
| Levered Free Cash Flow | -4.98 | -15.71 | -8.2 | -48.91 | -62.75 | |
| Unlevered Free Cash Flow | -4.98 | -15.71 | -8.2 | -48.91 | -62.75 | |
| Change in Working Capital | -38.28 | -11.95 | 76.34 | -2.12 | -11.4 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.